End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,100 KRW | +0.55% | +1.21% | -22.99% |
Business Summary
Number of employees: 63
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio
100.0
%
| 8,054 | 102.6 % | 9,481 | 100.0 % | +17.73% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
97.0
%
| 3,887 | 49.5 % | 9,197 | 97.0 % | +136.59% |
South Korea
3.0
%
| 3,964 | 50.5 % | 284 | 3.0 % | -92.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Yong-Ju Jeon
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Taek-Sung Kim
BRD | Director/Board Member | 59 | 15-03-26 |
Yeong-Kwon Jeong
BRD | Director/Board Member | 57 | - |
Yong-Jae Lee
SAM | Sales & Marketing | 61 | - |
Kwang-Hee Kim
PRN | Corporate Officer/Principal | 58 | - |
Yong-Ho Cho
AUD | Comptroller/Controller/Auditor | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Yeong-Kwon Jeong
BRD | Director/Board Member | 57 | - |
Taek-Sung Kim
BRD | Director/Board Member | 59 | 15-03-26 |
Jong-Sun Park
BRD | Director/Board Member | - | 18-03-26 |
Yong-Ju Jeon
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Jae-Moon Bae
BRD | Director/Board Member | 64 | 22-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,820,608 | 34,677,484 ( 87.08 %) | 2,256 ( 0.005665 %) | 87.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,256 | 0.01% | 35,191 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-22.99% | 591M | |
+12.23% | 388B | |
+10.21% | 132B | |
+16.52% | 76.2B | |
-16.82% | 62.43B | |
-9.10% | 47.67B | |
-10.82% | 36.76B | |
+5.49% | 34.51B | |
+10.61% | 15.35B | |
-4.57% | 11.3B |
- Stock Market
- Equities
- A048410 Stock
- Company Hyundai Bioscience Co., Ltd.